IPP Bureau
MedleyMed enters the U.S. market with a suite of digital health solutions
By IPP Bureau - September 26, 2021
The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021
AstraZeneca Pharma India receives permission for paediatric drug
By IPP Bureau - September 26, 2021
It paves way for the launch of Selumetinib 10 mg & 25 mg capsule in India, subject to the receipt of related statutory approvals and licenses
Novavax and Serum seek WHO approval for Covid-19 vaccine
By IPP Bureau - September 24, 2021
It is a recombinant nanoparticle protein-based vaccine
Surgery added to Practo’s offerings
By IPP Bureau - September 24, 2021
The company will leverage existing hospital and clinic partners’ infrastructure to build specialised `Experience Centres’ and facilitate a seamless, end-to-end secondary care surgery delivery. It will also offer healthcare financing
Zydus Cadila receives final approval for Apremilast
By IPP Bureau - September 24, 2021
Zydus' Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
AstraZeneca to collaborate with VaxEquity for self-amplifying RNA therapy
By IPP Bureau - September 24, 2021
saRNA is a new platform for the development of medicines and vaccines which uses similar technology to mRNA but with the added ability to self-amplify, thereby expressing proteins for longer, resulting in higher protein levels per dose level
Lancet publishes NanoFlu vaccine Phase 3 trial results
By IPP Bureau - September 24, 2021
The pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine
Health Sensei wins Stanford Seed Spark competition
By IPP Bureau - September 24, 2021
Seed Spark is an online entrepreneurship program offered by Stanford Seed. Health Sensei emerged as a winner competing with 86 startups from their May-Aug 2021 graduating cohort
Amaris Clinicals clears U.S. FDA audit
By IPP Bureau - September 24, 2021
The company is the Clinical Research Organisation of Caplin Point Laboratories
Aurobindo subsidiary submits MAA for oncology biosimilar
By IPP Bureau - September 23, 2021
CuraTeQ Biologics is on track for filing a second oncology biosimilar
Roche launches three respiratory test panels on Cobas 6800/8800 Systems in CE markets
By IPP Bureau - September 23, 2021
Three new molecular diagnostic test panels for influenza and other common respiratory illnesses can be run together or alone using one patient sample
Thermo Scientific introduces the NanoDrop Eight UV-Vis spectrophotometer
By IPP Bureau - September 23, 2021
The NanoDrop Eight simultaneously evaluates eight samples in 20 seconds or less and the instrument can also measure high-concentration samples of up to 200 absorbance units without dilution
Pfizer and BioNTech receive U.S. FDA EUA for Covid-19 booster
By IPP Bureau - September 23, 2021
Emergency Use Authorisation (EUA) is granted for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups
Lonza to expand its drug manufacturing network in Switzerland
By IPP Bureau - September 23, 2021
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
UFlex joins Alliance in its mission to end plastic waste
By IPP Bureau - September 23, 2021
UFlex has committed close to US $ 10 million towards various initiatives at its overseas and Indian plants to repurpose plastic waste
